Conference abstract · 2020
Conference abstractPublished 2018
Clinical Oncology 2018: Development of PI3K inhibitor Copanlisib – New insights and outlook - Ningshu Liu - Bayer AG, Germany
Subjects
Oncology & CancerMore from this journal
The newest in Research Journal of Oncology Open Access.
Conference abstract · 2020
Cancer Science 2019: Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment - Prof. Khawla Al-Kuraya - Director of the Research Centre at King Fahad National Centre for Children’s Cancer, King Faisal Specialist Hospital and Research (KFSH) in Riyadh, Saudi Arabia
Conference abstract · 2020
Ways to improve cancer aproach in Central and Eastern Europe
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalResearch Journal of Oncology Open Access
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ningshu Liu”
